Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. NBP211487E

Novus Biologicals™ TDRD1 Antibody Blocking Peptide
SDP

Catalog No. NBP211487E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.25 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP211487E 0.25 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP211487E Supplier Novus Biologicals™ Supplier No. NBP211487PEP
Add to Cart
Add to Cart

Description

Highly purified. Generating reliable and reproducible results.

Antigenic Blocking Peptide Tudor domain-containing protein 1. The TDRD1 Blocking Peptide is derived from Synthetic. The TDRD1 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 56165
Species Human
Purity >85%, by HPLC
Content And Storage Store at -20 C. Avoid freeze-thaw cycles.
Formulation Sodium Bicarbonate buffer, pH 8.00 containing up to 10% DMSO
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP2-11487. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias CT41.1 Cancer/testis antigen 41.1, FLJ21082, tudor domain containing 1, tudor domain containing protein 1, tudor domain-containing protein 1
Gene Symbol TDRD1
Product Type TDRD1
Quantity 0.25 mg
Regulatory Status RUO - research use only
Termination Blocking Peptide for NBP2-11487
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.